Could a PET scan replace biopsies for breast cancer patients?

NCT ID NCT07294430

Not yet recruiting Knowledge-focused Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 21 times

Summary

This pilot study explores whether a special PET scan using antibodies can predict how well a targeted cancer drug (T-DXd) works in people with advanced breast cancer. The goal is to see if this imaging method can replace the need for tumor biopsies. The study involves 30 patients who are already part of a larger research project.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.